₂₃Paul Rutgeerts

Summary for 2004 [at-glance overview of Paul Rutgeerts work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Paul Rutgeerts. According to available data, in 2004 Paul Rutgeerts published at least 23 articles. This work was completed in collaboration with several authors including Vermeire, Séverine and van Assche, Gert. Many other authors have collaborated with Paul Rutgeerts as well. There is no information about the funding or the grants awarded to support this work.

Paul Rutgeerts is a key opinion leader on Crohn Disease, Colitis, Ulcerative, Gastrointestinal Agents. This author's highest rank is 1 when compared to all other authors using the keyword Crohn Disease. Analysis of the article abstracts and the titles suggests that Paul Rutgeerts professional interests are focused around "inflammatory bowel disease", "score crohn disease" and "simple endoscopic score". These might also be referred to as "crohn disease", "inflammatory bowel" or "bowel disease". Statistical analysis shows that Paul Rutgeerts's writing is likely to contains terms "disease", "patients", "crohn", "treatment", "inflammatory" and "cd".

The affiliations of Paul Rutgeerts vary, with Department of Medicine, Division of Gastroenterology, University of Hospital Gasthuisberg, Leuven, Belgium being the most prominent. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Paul Rutgeerts]

Do you know Paul Rutgeerts who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Paul Rutgeerts]

₁₃₂Rutgeerts, P

Year 2004 Charts [Paul Rutgeerts frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Paul Rutgeerts publication and funding history for the range of years]

Emails (6) [email addresses extracted from Paul Rutgeerts affiliations]

hidden to prevent spam, click here to reveal

Paul Rutgeerts Coauthors (82) [all coauthors with the number of joint publications]

9

9

6

4

3

3

3

3

2

2

2

2

₅Rachmilewitz, Daniel

2

2

2

2

2

2

2

2

2

1

1

1

1

₁₆Bernstein, Charles N

1

₁₄Lichtenstein, Gary R

1

₁₃Colombel, Jean-Frédéric

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

₆van Deventer, Sander J

1

1

1

1

1

1

1

1

1

1

₃Aerts, Johannes M F G

1

₃Brandacher, Gerald

1

₃Bulois, Philippe

1

₃Chey, William Y

1

₃Colombel, Jean Frederic

1

1

1

1

1

1

1

1

1

1

1

1

₂Moschen, Alexander R

1

1

1

1

1

₁Bullens, Dominique M A

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (19) [condensed summary of the Paul Rutgeerts affiliations, the leading number and the color conveys importance]

₃Department of Medicine, Division of Gastroenterology, University of Hospital Gasthuisberg, Leuven, Belgium.
₁Department of Gastroenterology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.
₁Laboratory Medicine, Immunology, Internal Medicine, Gastroenterology, Department of Paediatrics, Department of Pathology, University Hospital, Leuven, Belgium.
₁Gastroenterology Unit, Ospedale Mauriziano Umberto I, Torino, Italy.
₁Department of Medicine, Division of Gastroenterology and Hepatology, University Hospital Innsbruck, Internal Medicine, Innsbruck, Austria.
₁Department of Nuclear Medicine, Academic Medical Center, Amsterdam, The Netherlands.
₁Clinical Immunology, University Hospital, Katholieke Universiteit Leuven, Leuven, Belgium.
₁Department of Medicine, University of Chicago Medical Center, Chicago, Illinois, USA.
₁Department of Gastroenterology, University Hospital Gasthuisberg, KULeuven, Leuven, Belgium.
₁Department of Gastroenterology and Nutrition, University of Chicago Medical Center, IL 60637, USA.
₁Laboratory of Experimental Immunology, Catholic University of Leuven, Campus Gasthuisberg (O&N), Herestraat 49, B-3000 Leuven, Belgium.
₁Laboratory of Molecular Immunology, Rega Institute for Medical Research, University of Leuven, Leuven, Belgium.
₁Division of Gastroenterology, Department of Internal Medicine, University Hospital Leuven, 49 Herestraat, B-3000 Leuven, Belgium.
₁Department of Gastroenterology, University Hospital Gasthuisberg, Catholic University of Leuven, 3000 Leuven, Belgium.
₁Department of Internal Medicine, University Hospital, Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.
₁Afdeling Gastroenterologie, Universitair Ziekenhuis Gasthuisberg, Leuven, Belgium.
₁Department of Gastroenterology, UZ Gasthuisberg, Leuven, Belgium.
₁Gastrointestinal Unit, Massachusetts General Hospital, and Harvard Medical School, Boston 02114, USA.
₁Division of Gastroenterology, Leuven University Hospital, Herestraat 49, 3000 Leuven, Belgium.

Key Opinion Leader In [Paul Rutgeerts is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁Crohn Disease | ₂Gastrointestinal Agents | ₃Colitis, Ulcerative | ₆Antibodies | ₁₇Colectomy | ₂₀Infusions, Intravenous | ₂₁Antibodies, Monoclonal | ₂₁Tumor Necrosis Factor-alpha | ₂₁Inflammatory Bowel Diseases | ₃₁Recurrence | ₇₂Double-Blind Method | ₇₈Immunosuppressive Agents | ₈₂Drug Administration Schedule | ₁₀₂Inflammation | ₁₁₄Treatment Outcome | ₂₁₈Severity of Illness Index | ₂₅₉Risk Assessment | ₃₈₂Adult | ₄₂₃Dose-Response Relationship, Drug | ₄₉₈Sensitivity and Specificity | ₆₇₁Male | ₇₅₆Humans | ₇₆₈Female

Keywords (32) [keywords assigned to Paul Rutgeerts articles by PubMed, the leading number and the color conveys importance]

₂₂Humans | ₁₅Male | ₁₄Crohn Disease | ₁₄Female | ₁₂Adult | ₁₀Middle Aged | ₈Treatment Outcome | ₇Aged | ₆Tumor Necrosis Factor-alpha | ₆Colitis, Ulcerative | ₆Antibodies, Monoclonal | ₅Gastrointestinal Agents | ₄Adolescent | ₄Immunosuppressive Agents | ₄Antibodies | ₄Recurrence | ₄Double-Blind Method | ₃Infusions, Intravenous | ₃Inflammatory Bowel Diseases | ₃Severity of Illness Index | ₃Aged, 80 and over | ₃Sensitivity and Specificity | ₃Colectomy | ₃Drug Administration Schedule | ₃Dose-Response Relationship, Drug | ₃Inflammation | ₃Risk Assessment | ₂RNA, Messenger | ₂Interferon-gamma | ₂Reproducibility of Results | ₂Biological Markers | ₂Belgium

Paul Rutgeerts Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Paul Rutgeerts might be a good expert witness on these terms]

₆₈disease | ₆₆patients | ₄₄crohn | ₂₅treatment | ₂₅inflammatory | ₂₄cd | ₂₁bowel | ₁₉endoscopic | ₁₈infliximab | ₁₇cells | ₁₆colitis | ₁₅ibd | ₁₃therapy | ₁₂antibody | ₁₂clinical | ₁₂intestinal | ₁₂uc | ₁₂response | ₁₁maintenance | ₁₁score | ₁₁tissue | ₁₀expression | ₁₀csa | ₁₀compared | ₁₀conclusions | ₁₀ulcerative | ₉episodic | ₉recurrence | ₉associated | ₈protein | ₈il-8 | ₈activity
₄₃crohn disease | ₁₇inflammatory bowel | ₁₃bowel disease | ₁₁cd patients | ₁₀ulcerative colitis | ₈score crohn | ₇endoscopic score | ₆ibd patients | ₆simple endoscopic | ₅disease cd | ₅infliximab maintenance | ₄bowel diseases | ₄uc patients | ₄episodic treatment | ₄patients treated | ₄test meal | ₄intestinal tissue | ₄infusion reactions | ₄colitis uc | ₃inflamed intestinal | ₃infliximab treatment | ₃c-reactive protein | ₃anti-tnf strategies | ₃gcp-2 cxcl6 | ₃postoperative recurrence | ₃celiac disease | ₃treatment crohn | ₃endoscopic activity | ₃recurrence crohn | ₃index severity | ₃cxcr1-binding chemokines | ₃selective gcp-2
₁₃inflammatory bowel disease | ₈score crohn disease | ₆simple endoscopic score | ₆endoscopic score crohn | ₄crohn disease cd | ₄inflammatory bowel diseases | ₄ulcerative colitis uc | ₃inflamed intestinal tissue | ₃recurrence crohn disease | ₃postoperative recurrence crohn | ₃crohn disease endoscopic | ₃disease endoscopic index | ₃fistulizing crohn disease | ₃treatment crohn disease | ₃endoscopic index severity | ₃endoscopic activity score | ₂maintenance therapy fistulizing | ₂treatment response predicting | ₂c-reactive protein marker | ₂placebo 2-year trial | ₂therapy fistulizing crohn | ₂mesalamine placebo 2-year | ₂indoleamine 3-dioxygenase human | ₂cells cd patients | ₂maintenance episodic treatment | ₂tissue transglutaminase antibody | ₂patients ulcerative colitis | ₂validation test meal | ₂chemokines inflammatory bowel | ₂lamina propria cells | ₂gcp-2 cxcl6 expression | ₂selective gcp-2 cxcl6

Reader's Comments (0) [comments posted by readers of Paul Rutgeerts profile]